The Effects of ARBs, ACEis, and Statins on Clinical Outcomes of COVID-19 Infection Among Nursing Home Residents

OBJECTIVES: Angiotensin-converting enzyme inhibitors (ACEi), angiotensin II receptor blockers (ARBs), and HMG-CoA reductase inhibitors (“statins”) have been hypothesized to affect COVID-19 severity. However, up to now, no studies investigating this association have been conducted in the most vulnera...

Descripción completa

Detalles Bibliográficos
Autores principales: De Spiegeleer, Anton, Bronselaer, Antoon, Teo, James T., Byttebier, Geert, De Tré, Guy, Belmans, Luc, Dobson, Richard, Wynendaele, Evelien, Van De Wiele, Christophe, Vandaele, Filip, Van Dijck, Diemer, Bean, Dan, Fedson, David, De Spiegeleer, Bart
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AMDA - The Society for Post-Acute and Long-Term Care Medicine. 2020
Materias:
Original Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7294267/
https://www.ncbi.nlm.nih.gov/pubmed/32674818
http://dx.doi.org/10.1016/j.jamda.2020.06.018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7294267/
https://www.ncbi.nlm.nih.gov/pubmed/32674818
http://dx.doi.org/10.1016/j.jamda.2020.06.018

Ejemplares similares